Liposarcoma other diagnostic studies

Liposarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Liposarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Liposarcoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Liposarcoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Liposarcoma other diagnostic studies
CDC on Liposarcoma other diagnostic studies
Liposarcoma other diagnostic studies in the news
Blogs on Liposarcoma other diagnostic studies
Directions to Hospitals Treating Liposarcoma
Risk calculators and risk factors for Liposarcoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Genetic assessment is one of the other diagnostic test for liposarcoma

Genetic assessment

The goals, risks and benefit of genetic assessment are numerous. A number of genetic conditions are associated with liposarcoma. Li-Fraumeni syndrome are the most common disease associated with it. The genes for TP53 mutations are tested in the tissue sample to detect Li-Fraumeni syndrome.